primary open angle glaucoma
Conditions
Sponsors
Nippon Medical School Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with unilateral or bilateral primary open angle glaucoma Patients who can visit the hospital according to the observation/test schedule determined in the study protocol
Exclusion criteria
Exclusion criteria: Patients with some corneal abnormality or other diseases which may interfere with accurate IOP measurement using Goldmann applanation tonometer Patients with a history of corneal refractive surgery Patients with active extraocular disease, inflammation or infection in the eye(s) or eyelid(s) Patients with allergy to the ingredients used in the present study Pregnant, lactating women or women who may be pregnant, and women who wish to be pregnant or can not conduct appropriate contraception during the study period Patients who are contraindicated to beta blockers (those who with bronchial asthma or insufficiently controlled heart failure)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean 24-hour IOP after the drug was administered for 8 weeks | — |
Countries
Japan
Contacts
Public ContactKenji Nakamoto
Nippon Medical School Hospital Ophthalmology
Outcome results
None listed